Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Shift4 Named Exclusive PointofSale Systems Partner of the New York Yankees

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
From Novice to Expert: Navigating the Cryptocurrency Learning Curve
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Shift4 was announced as the exclusive Point-of-Sale Systems Partner of the New York Yankees, revolutionizing the commerce experience at Yankee Stadium and George M. Steinbrenner Field in Tampa.

This groundbreaking partnership is set to elevate the transaction process for guests, providing a seamless and secure payment solution. Marty Greenspun, SVP of Strategic Ventures for the New York Yankees, expressed enthusiasm for the collaboration, anticipating Shift4’s innovative capabilities to streamline operations at the venues.

Michael Isaacman, Shift4’s Chief Commercial Officer, underscored the company’s dedication to delivering a top-tier gameday experience for fans through their cutting-edge commerce ecosystem.

FOUR Stock Price Surges 5.55% on February 28, 2024: Strong Momentum Continues in After-Hours Trading

On February 28, 2024, FOUR, a stock listed on the stock market, showed impressive performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates strong price momentum for the stock.

The price of FOUR shares saw a significant increase on this day, rising by $4.04 since the market last closed. This represented a substantial 5.55% increase in the stock price, closing at $76.83. Furthermore, in after-hours trading, the stock continued to show positive momentum by rising an additional $0.03.

This strong performance by FOUR reflects investor confidence in the company and its potential for growth. Investors who have invested in FOUR may be pleased with the stock’s performance on February 28, 2024, as it demonstrated a significant increase in value and continued to show positive momentum in after-hours trading.

Top Performing Stocks: Stock A Sees Impressive Revenue and Profit Growth in 2024

On February 28, 2024, four stocks showed impressive performances based on their financial data. Let’s take a closer look at each of these stocks:

1. Stock A:
Total Revenue: $1.99B (1Y), $675.40M (Q3)
Net Income: $75.10M (1Y), $32.60M (Q3)
Earnings per share: $1.05 (1Y), $0.55 (Q3)

Stock A has seen a significant increase in both total revenue and net income since last year and last quarter. The total revenue increased by 43.36% year-over-year and 6.03% quarter-over-quarter. Net income also saw a substantial increase of 253.58% year-over-year and 29.88% quarter-over-quarter. Earnings per share also showed impressive growth, increasing by 217.66% since last year and 31.4% since last quarter. This indicates that Stock A is performing well and generating strong profits for its shareholders.

Tags: FOUR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare cloud based

Wedbush Analyst Maintains Neutral Rating on Regenxbio with 21 Price Target

Investings on laptop and finances

Wedbush Analyst Reiterates Confidence in Kura Oncology with Outperform Rating and 37 Price Target

Energy Company Markets and money

Global Partners LP Positioned for Strong Growth in 2024

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com